Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Urology Physician in Tampa, FL
NPI: 1326157082Primary Employer
Moffitt Medical Group
moffitt.org
HQ Phone
Get M.D. Philippe's Phone Numberphone_androidMobile
Get M.D. Philippe's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2007 - 2027
TX State Medical License
2006 - 2007
American Board of Urology
Urology
McGill University Faculty Medicine Hospital
1999 - 2004
1999 - 2004
University of Toronto Faculty of Medicine
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 52000Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 110 | 185 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 53 | 53 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 45 | 50 |
| 4 | 74420Imaging of urinary tract | 23 | 26 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 13 | 15 |
HPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights.
Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level.
Authors: Curtis Pettaway
Publication Date: 2007-01
Authors: Curtis Pettaway
Journal: J Urol
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Endo Pharmaceuticals
Intervention / Treatment: DRUG: Valrubicin
Lead Sponsor: Endo Pharmaceuticals
Intervention / Treatment: DRUG: VALSTAR - Maintenance Therapy, OTHER: No Maintenance treatment ( Standard of Care)
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD)
Intervention / Treatment: DRUG: Purified isoflavones, DRUG: Methyl cellulose blend